Aikido Pharma Inc expected to post a loss of 1cent a share - Earnings Preview

Dominari Holdings

21/03/2022 20:15

* Aikido Pharma Inc  AIKI.OQ   AIKI.O  is expected to report
results on March 23 (estimated).
    * ​Refinitiv's mean analyst estimate for Aikido Pharma Inc
is for
a loss of 1 cent per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aikido
Pharma Inc
is $2​, above​ its last closing price of $0.43. ​​​

This summary was machine generated March 21 at 20:15 GMT.  All
figures in US dollars  unless otherwise stated